PMAC 2016 Side Event (SE 012): Health Intervention and Technology Assessment (HITA): A Path to Universal Health Coverage (UHC)Given the global push to implement UHC, the importance of using evidence, namely health intervention and technology assessments (HITA), in governments’ decision making proces

A new oral medication to treat patients in the early stages of multiple sclerosis has shown considerable promise in two clinical trials, researchers announced on Wednesday.The medication is on track to become just the third oral drug available to M.S. patients, and potentially the safest and most ef

The settlement is part of a broad crackdown on bribery by multinational companies in foreign countries that has hit several of the world’s biggest pharmaceutical companies.Pfizer in 2004 became the first pharmaceutical company to volunteer information about past wrongdoing to the Justice Department,

Up to a million people in the UK have “completely preventable” severe headaches caused by taking too many painkillers, doctors have said.They said some were trapped in a “vicious cycle” of taking pain relief, which then caused even more headaches.The warning came as part of the National Institute fo

About one in six children and teenagers are also obese, according to the Journal of the American Medical Association report which showed that obesity remains a significant problem in US society despite efforts to combat it.“Obesity prevalence shows little change over the past 12 years, although the

(Reuters) – An experimental drug from Novartis may help up to half of heart failure patients for whom no effective treatment is available, although the evidence so far is indirect.Results of a mid-stage clinical trial of the drug known as LCZ696, unveiled on Sunday, gauged its effectiveness by measu

The Affordable Care Act of 2010 greatly expanded women’s access to free preventive services, particularly for sexual and reproductive health . Men didn’t fare nearly as well.The ACA guidelines’ promise of free contraception may have generated the most controversy, but the law also provides many othe

Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences. Rob Baltussen1, Sitapon Youngkong11,2, Francesco Paolucci3, Louis Niessen4 1 Department of Primary and Community Care, Radboud University Nijmegen Medical Center, The Netherlands 2 Health I

หากคุณมีผลงานที่ยกระดับสุขภาพ และมีระดับความพร้อมทางเทคโนโลยี (Technology Readiness Level: TRL) ระดับ 5 – 9 เราขอเชิญให้คุณร่วมประกวดโดยส่ง Abstract แนะนำนวัตกรรมที่กำลังวิจัยและพัฒนา เพื่อค้นหาสุดยอดนวัตกรรมด้านการแพทย์ในงาน “MIDAS Medical Innovation Hackathon 2025” ที่จะจัดขึ้นในวันที่ 15-16 กุมภา